yeah looks very promising perhaps as much as a 1.5 bil opportunity on top of CG; next 10 days or so should be quite interesting as we have annual meeting Thursday and then earnings call aug 1 … i'm most interested in the guidance given on the call. I think we get to 1 mil tests in 2018. More color on liverguard should enable the analysts to start dcf model on its revenue. Liverguard will be a lot more profitable per test than CG.
News 
Market Data 
Discover 
